Plain-English translation of NCT07357831 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This study is testing a new medication called to see if it works well for plaque psoriasis — a skin condition that causes thick, scaly patches. Researchers want to know if this cream is better than a similar existing treatment and better than a placebo cream with no active ingredients. The study will involve about 537 people in China.
Plaque psoriasis can be uncomfortable and affect quality of life, and doctors are always looking for better treatment options. This trial will help determine whether this medication offers an improvement over treatments currently available.
You likely qualify if…
You likely don't qualify if…
You would apply the assigned cream to your skin once daily for 8 weeks. You would be randomly assigned to receive either the new , a placebo cream with no active ingredient, or an existing comparison cream. Throughout the study, you would visit the clinic for check-ups to see how your skin is responding and to monitor for any side effects.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
China